Leading the Pack – Advanced Clinical Trial Insights to Prepare for the Latest Phases of Development
Time: 8:30 am
day: Day One
Details:
- Clinical overview of agents targeting adenosine pathway in cancer
- Emerging clinical results with Oleclumab (anti-CD73 mAb)
- What’s the next move for large players and what opportunities could this lead to?
